PROTAC FKBP Degrader-3
98%
- Product Code: 106389
CAS:
2079056-43-0
| Molecular Weight: | 1295.54 g./mol | Molecular Formula: | C₆₈H₉₀N₆O₁₇S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
PROTAC FKBP Degrader-3 is utilized in targeted protein degradation studies, particularly in the field of chemical biology and drug discovery. It is designed to selectively degrade FKBP proteins, which are involved in various cellular processes, including protein folding and signaling. This compound is employed in research to understand the role of FKBP proteins in disease pathways and to explore potential therapeutic strategies. By inducing the degradation of specific proteins, it helps in studying the effects of protein loss on cellular functions and disease models. Additionally, it serves as a tool for validating FKBP as a drug target in conditions where its overexpression or malfunction is implicated, such as cancer, neurodegenerative disorders, and immune-related diseases. Its application extends to the development of PROTAC-based therapies, offering a novel approach to drug design that goes beyond traditional inhibition.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | ฿67,320.00 |
+
-
|
| 0.005 | 10-20 days | ฿134,100.00 |
+
-
|
PROTAC FKBP Degrader-3
PROTAC FKBP Degrader-3 is utilized in targeted protein degradation studies, particularly in the field of chemical biology and drug discovery. It is designed to selectively degrade FKBP proteins, which are involved in various cellular processes, including protein folding and signaling. This compound is employed in research to understand the role of FKBP proteins in disease pathways and to explore potential therapeutic strategies. By inducing the degradation of specific proteins, it helps in studying the effects of protein loss on cellular functions and disease models. Additionally, it serves as a tool for validating FKBP as a drug target in conditions where its overexpression or malfunction is implicated, such as cancer, neurodegenerative disorders, and immune-related diseases. Its application extends to the development of PROTAC-based therapies, offering a novel approach to drug design that goes beyond traditional inhibition.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :